Bone involvement in the early stages of Parkinson's disease: a case–control study

Sara Liguori,Antimo Moretti,Marco Paoletta,Fiorinda Gargiulo,Giuseppe Barra,Francesca Gimigliano,Giovanni Iolascon
DOI: https://doi.org/10.1177/03000605241237880
2024-03-24
Journal of International Medical Research
Abstract:Journal of International Medical Research, Volume 52, Issue 3, March 2024. ObjectiveTo evaluate the qualitative and quantitative alterations of bone tissue in patients with early-stage Parkinson's disease (PD) and to measure the associations between bone mineral density (BMD), trabecular bone score (TBS) and physical performance.MethodsThis case–control study enrolled patients with early-stage PD and age-matched controls. BMDs for the left femoral neck (L-FN) and lumbar spine (LS) were measured. Bone microarchitecture for the LS was determined using TBS. Muscle performance was assessed using the short physical performance battery (SPPB). Patients and controls were stratified in two groups based on the SPPB score: a poor performance group (SPPB score ≤8) and high performance group (SPPB > 8).ResultsThis study included 26 patients: 13 in the PD group and 13 age-matched controls. The mean ± SD BMD results in the PD group were: L1–L4 BMD = 0.935 ± 0.183 g/cm2; L-FN BMD = 0.825 ± 0.037 g/cm2; with bone microarchitecture degraded in four patients and partially degraded in three patients. TBS was significantly different in the patients with PD stratified according to SPPB. Among the controls, there was a significant difference in body mass index between the two SPPB groups.ConclusionTBS might identify bone involvement earlier than BMD in the initial stages of PD.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?